Medical cannabis in the treatment of cancer pain and spastic conditions and options of drug delivery in clinical practice
The use of cannabis for medical purposes has been recently legalised in many countries including the Czech Republic.
Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State
Research on the patterns of use of medical cannabis among cancer patients is lacking. CBD; THC; cancer; cannabis; medical marijuana.
Opportunities for cannabis in supportive care in cancer
Cannabis has the potential to modulate some of the most common and debilitating symptoms of cancer and its treatments, including nausea and vomiting, loss of appetite, and pain.
Epidemiology of Lung Cancer
Lung cancer continues to be one of the most common causes of cancer death despite understanding the major cause of the disease: cigarette smoking.
Cannabinoid signaling in health and disease
Cannabis sativa has long been used for medicinal purposes.
The Use of Medical Marijuana in Cancer
The use of medical marijuana in cancer care presents a dilemma for both patients and physicians.
Pharmacology of Medical Cannabis
The Cannabis plant has been used for many of years as a medicinal agent in the relief of pain and seizures.
Pharmacology of Medical Cannabis
The Cannabis plant has been used for many of years as a medicinal agent in the relief of pain and seizures. It contains approximately 540 natural compounds including more than 100 that have been identified as phytocannabinoids due to their shared chemical structure. The legalization of cannabis for medicinal purposes and for recreational use in some regions will allow for much needed research on the pharmacokinetics and pharmocology of medical cannabis. This brief review focuses on the use of cannabis as a medicinal agent in the treatment of pain, epilepsy and neurodegenerative diseases. Despite the paucity of information, attention is paid to the mechanisms by which medical cannabis may act to relieve pain and seizures.
Epilepsy and Cannabis: A Literature Review
Epilepsy is considered to be one of the most common non-communicable neurological diseases especially in low to middle-income countries. Approximately one-third of patients with epilepsy have seizures that are resistant to antiepileptic medications. Clinical trials for the treatment of medically refractory epilepsy have mostly focused on new drug treatments, and result in a significant portion of subjects whose seizures remain refractory to medication. The off-label use of cannabis sativa plant in treating seizures is known since ancient times. The active ingredients of this plant are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), the latter considered safer and more effective in treating seizures, and with less adverse psychotropic effects.
Prospects for the Use of Cannabinoids in Oncology and Palliative Care Practice: A Review of the Evidence
There is an increased interest in the use of cannabinoids in the treatment of symptoms in cancer and palliative care patients. Their multimodal action, in spite of limited efficacy, may make them an attractive alternative, particularly in patients with multiple concomitant symptoms of mild and moderate intensity. There is evidence to indicate cannabis in the treatment of pain, spasticity, seizures, sleep disorders, nausea and vomiting, and Tourette syndrome.